US Patent Issued to Amylyx Pharmaceuticals, The Board of Trustees of the Leland Stanford Junior University on Nov. 3 for "Buffered formulations of exendin (9-39)" (California Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,779,039, issued on Nov. 3, was assigned to Amylyx Pharmaceuticals Inc. (Cambridge, Mass.) and The Board of Trustees of the Leland Stanford Junior University (Stanford, Calif.).

"Buffered formulations of exendin (9-39)" was invented by Xiaofeng Xiong (Santa Clara, Calif.), Debra Odink (Oakland, Calif.), Colleen M. Craig (Burlingame, Calif.), Christine M.N. Smith (San Diego) and Tracey L. McLaughlin (Santa Clara, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are liquid pharmaceutical formulations comprising exendin (9-39) or a pharmaceutically acceptable salt thereof and a tonicity modifier in a physiologically acceptable buffer hav...